Diabetes Mellitus, Type II
81
2
3
58
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
18 trials with published results (22%)
Research Maturity
58 completed trials (72% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.2%
5 terminated out of 81 trials
92.1%
+5.6% vs benchmark
26%
21 trials in Phase 3/4
31%
18 of 58 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 58 completed trials
Clinical Trials (81)
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
Technology Intensified Diabetes Education Study in African Americans
Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations (Phase II)
Detection of Diffuse Scar in Patients With Diabetes
TARDIS - Photo Elicitation and Intervention
Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus
The EMPA-FIT Study
Evaluation of the Effect of Nurse Coaching Program on Self-management and Skin Care Behaviors in Patients With Diabetes
Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM
Micro-Clinic Obesity and Metabolic Risk Prevention Program
Fenofibrate in Type 2 Diabetes
Development and Exploration of the Effectiveness and Feasbility of a Digital Intervention for Type 2 Diabetes Mellitus
Differences in Postprandial Glucose Changes
Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
Impact of Periodontal Therapy on Patients With Diabetes
A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus
A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus
Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)
Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-Responders
Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics